Last reviewed · How we verify
Calcium Gluceptate (calcium glucoheptonate)
At a glance
| Generic name | calcium glucoheptonate |
|---|---|
| Sponsor | Abbott |
| Drug class | calcium glucoheptonate |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1972 |
Approved indications
- Cardiac arrest
- Disorder of electrolytes
- Hyperkalemia
- Hypermagnesemia
- Hypocalcemia
- Hypocalcemic tetany
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Calcium Gluceptate CI brief — competitive landscape report
- Calcium Gluceptate updates RSS · CI watch RSS
- Abbott portfolio CI